Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Acrivon Therapeutics, Inc.
organization1 mentionslast seen Nov 6, 2026
Clinical-stage biopharmaceutical company discovering and developing precision medicines for oncology and inflammatory diseases.
Relationships 9
- Acrivon Therapeutics, Inc.acquiresAqilion AB98% confidence1 source
- Acrivon Therapeutics, Inc.acquiresPKCθ inhibitor98% confidence1 source
- Acrivon Therapeutics, Inc.acquiresACR-52598% confidence1 source
- Acrivon Therapeutics, Inc.employsPeter Blume-Jensen97% confidence1 source
- Acrivon Therapeutics, Inc.developsACR-36896% confidence1 source
- Acrivon Therapeutics, Inc.developsAcrivon Predictive Precision Proteomics96% confidence1 source
- Acrivon Therapeutics, Inc.developsACR-231696% confidence1 source
- Acrivon Therapeutics, Inc.developsACR-728096% confidence1 source
- Acrivon Therapeutics, Inc.developsACR-52585% confidence1 source
Relationship
Acrivon Therapeutics, Inc.acquiresACR-525
98% confidence1 supporting mentionsfrom Nov 6, 2026
Either name opens that entity’s relationships.
Sources 1